Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia
NCT ID: NCT04348799
Last Updated: 2020-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2019-01-01
2020-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China
NCT03850457
Biomarkers and Volumetric Capnography in BPD
NCT02083562
Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates
NCT05071638
Autologous Cord Blood Cells for Prevention of BPD in Preterm
NCT04311476
Analysis of BPD in Premature Infants With Typical Imaging Changes
NCT04163822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BPD group
premature infants diagnosed with BPD after postnatal day 28
BPD
It is a observation research.we didn't intervene anything.
control group
premature infants without BPD after postnatal day 28
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BPD
It is a observation research.we didn't intervene anything.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. presence of peripheral arterial catheter;
3. gestation \<32 weeks;
4. birth weight \<1.5 kg;
5. requiring mechanical ventilation for the treatment of respiratory distress syndrome for at least 3 days during the first weeks of life;
6. ventilator and/or oxygen dependent at time of enrolment;
Exclusion Criteria
2. infection (bacteria infection confirmed by positive blood culture or viral infection confirmed by serological test or viral culture)
3. evidence of complications of perinatal asphyxia including an apgar score \<3 at one or five minute after birth, evidence of hypoxic-ischemic encephalopathy, acute tubular necrosis, or transient myocardial ischemia;
4. identifiable hematologic disease;
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
yangjie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yangjie
Director of Dept of Neonatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jie Yang
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Guangdong W C H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.